Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare ziprasidone (Geodon) monotherapy for the treatment of
psychotic major depression (PMD)with an antidepressant/antipsychotic combined therapy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborators:
National Institute of Mental Health and Neuro Sciences, India Pfizer